Literature DB >> 29624150

Frequency and characteristics associated with inherited thrombophilia in patients with intracranial dural arteriovenous fistula.

Sara C LaHue1,2, Helen Kim3,4, Ludmila Pawlikowska3,4, Jeffrey Nelson3, Daniel L Cooke5, Steven W Hetts5, Vineeta Singh1,2.   

Abstract

OBJECTIVEThe pathogenesis of dural arteriovenous fistulas (DAVFs) remains poorly defined. Prior studies on thrombophilia as a risk factor for DAVF development are limited by small sample sizes and poor generalizability.METHODSIn this longitudinal observational study, all patients with intracranial DAVFs evaluated at the University of California, San Francisco from December 1994 through April 2014 were identified. After obtaining patient consent, 3 thrombophilic mutations, factor V Leiden (rs6025), MTHFR (rs1801133), and prothrombin G20210A, were genotyped. The authors evaluated the association of thrombophilia status (presence of any thrombophilic mutation) and clinical and angiographic characteristics using either a 2-sample t-test or Fisher's exact test.RESULTSA total of 116 patients with diagnosed intracranial DAVFs were included in the study. Twenty-five (22%) patients met criteria for thrombophilia. Focal neurological deficits tended to occur more frequently in the thrombophilia group (78% vs 57%, p = 0.09). Angiographic characteristics of DAVFs, including high-risk venous flow pattern, multiplicity of DAVF, and the presence of venous sinus thrombosis, did not differ significantly between the 2 groups but tended to be more common in the thrombophilic than in the nonthrombophilic group.CONCLUSIONSThis study is one of the largest of thrombophilia and DAVF to date. The frequency of mutations associated with thrombophilia in this study was higher than that in the general population.

Entities:  

Keywords:  DAVF = dural arteriovenous fistula; MTHFR; UCSF = University of California, San Francisco; dural arteriovenous fistula; factor V Leiden; mRS = modified Rankin Scale; prothrombin; thrombophilia; vascular disorders

Year:  2018        PMID: 29624150      PMCID: PMC6173991          DOI: 10.3171/2017.10.JNS171987

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  35 in total

1.  Benign cranial dural arteriovenous fistulas: outcome of conservative management based on the natural history of the lesion.

Authors:  Junichiro Satomi; J Marc C van Dijk; Karel G Terbrugge; Robert A Willinsky; M Christopher Wallace
Journal:  J Neurosurg       Date:  2002-10       Impact factor: 5.115

2.  Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening.

Authors:  P M Ridker; J P Miletich; C H Hennekens; J E Buring
Journal:  JAMA       Date:  1997 Apr 23-30       Impact factor: 56.272

3.  Management, risk factors and outcome of cranial dural arteriovenous fistulae: a single-center experience.

Authors:  Stephan Dützmann; Jürgen Beck; Rüdiger Gerlach; Andrea Bink; Joachim Berkefeld; Richard du Mesnil de Rochement; Volker Seifert; Andreas Raabe
Journal:  Acta Neurochir (Wien)       Date:  2011-03-20       Impact factor: 2.216

4.  Thrombophilic risk factors in patients with cranial and spinal dural arteriovenous fistulae.

Authors:  Rüediger Gerlach; Martina Boehm-Weigert; Joachim Berkefeld; Judith Duis; Andreas Raabe; Volker Seifert; Gerhard Marquardt
Journal:  Neurosurgery       Date:  2008-10       Impact factor: 4.654

5.  Development of acquired arteriovenous fistulas in rats due to venous hypertension.

Authors:  T Terada; R T Higashida; V V Halbach; C F Dowd; M Tsuura; N Komai; C B Wilson; G B Hieshima
Journal:  J Neurosurg       Date:  1994-05       Impact factor: 5.115

6.  Genesis of a dural arteriovenous malformation in a rat model.

Authors:  J M Herman; R F Spetzler; J B Bederson; J M Kurbat; J M Zabramski
Journal:  J Neurosurg       Date:  1995-09       Impact factor: 5.115

7.  Prevalence of the C677T substitution of the methylenetetrahydrofolate reductase (MTHFR) gene in Wisconsin.

Authors:  Zhongxia Qi; Gary Hoffman; Daniel Kurtycz; Jingwei Yu
Journal:  Genet Med       Date:  2003 Nov-Dec       Impact factor: 8.822

8.  Dural arteriovenous malformation of the major venous sinuses: an acquired lesion.

Authors:  M Y Chaudhary; V P Sachdev; S H Cho; I Weitzner; S Puljic; Y P Huang
Journal:  AJNR Am J Neuroradiol       Date:  1982 Jan-Feb       Impact factor: 3.825

9.  Thrombophilic factors and the formation of dural arteriovenous fistulas.

Authors:  J Marc C van Dijk; Karel G TerBrugge; Felix J Van der Meer; M Christopher Wallace; Frits R Rosendaal
Journal:  J Neurosurg       Date:  2007-07       Impact factor: 5.115

10.  ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing.

Authors:  Scott E Hickey; Cynthia J Curry; Helga V Toriello
Journal:  Genet Med       Date:  2013-01-03       Impact factor: 8.822

View more
  2 in total

1.  Gradual dilatation of an occluded transverse sinus associated with dural arteriovenous fistula after balloon angioplasty with sinus packing: A case report.

Authors:  Takuya Osuki; Hiroyuki Ikeda; Tomoko Hayashi; Silsu Park; Minami Uezato; Masanori Kinosada; Yoshitaka Kurosaki; Akira Handa; Masaki Chin
Journal:  Neuroradiol J       Date:  2021-08-23

2.  Hypercoagulability in patients with indirect carotid cavernous fistulas.

Authors:  Trishal Jeeva Patel; Kirill Zaslavsky; Patrick Nicholson; Edward Margolin
Journal:  Eye (Lond)       Date:  2021-10-11       Impact factor: 4.456

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.